Allosteric activation of a cell-type-specific GPR120 inhibits amyloid pathology of Alzheimer's disease.

While there was a trend suggesting potential differences during the probe trials, these did not reach statistical significance, indicating that administration of ALA or EDA alone is therapeutically ineffective against learning and memory declines in APP/PS1 mice.

also in 111,027 other papers